Suppr超能文献

肾钠/钙交换体;一种在盐敏感性高血压中存在缺陷的血管舒张剂。

Renal sodium/calcium exchange; a vasodilator that is defective in salt-sensitive hypertension.

作者信息

Bell P D, Mashburn N, Unlap M T

机构信息

Nephrology Research and Training Center, Departments of Medicine and Physiology, Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

出版信息

Acta Physiol Scand. 2000 Jan;168(1):209-14. doi: 10.1046/j.1365-201x.2000.00671.x.

Abstract

The Na+ : Ca2+ exchanger is an important plasma membrane ion transport pathway that plays a major role in controlling [Ca2+]i. In smooth muscle cells, it may function as a Ca2+ extrusion pathway and may help lower [Ca2+]i in response to vasoconstrictor-induced increases in [Ca2+]i. It may also extrude [Ca2+]i and lead to vasodilation in response to vasodilators. Our recent studies have been performed to determine the existence and regulation of the Na+ : Ca2+ exchanger in renal contractile cells which include afferent and efferent arterioles and mesangial cells. Exchanger activity is present in all three of these contractile elements but is higher in afferent arterioles vs. efferent arterioles. We have also examined the role of altered regulation of the exchanger in the SHR and in salt-sensitive hypertension. With the establishment of high blood pressure, Na+ : Ca2+ exchanger activity is reduced in afferent but not in efferent arterioles in both models of hypertension. Other works in cultured mesangial cells and freshly dissected afferent arterioles, have shown that protein kinase C (PKC) up-regulates the Na+ : Ca2+ exchanger from Dahl/Rapp salt-resistant rats while it fails to do so in arterioles and mesangial cells from salt-sensitive rats. This defect in PKC regulation of Na+ : Ca2+ exchange is the result of a loss of PKC-mediated translocation of the exchanger to the plasma membrane in S mesangial cells. Thus, a defect in the PKC-Na+ : Ca2+ exchanger-translocation pathway may cause dysregulation of [Ca2+]i and help explain the dramatic decrease in GFR that occurs in this model of hypertension.

摘要

钠钙交换体是一种重要的质膜离子转运途径,在控制细胞内钙离子浓度([Ca2+]i)方面发挥着主要作用。在平滑肌细胞中,它可能作为一种钙离子排出途径,有助于在血管收缩剂诱导[Ca2+]i升高时降低细胞内钙离子浓度。它也可能在血管舒张剂作用下排出[Ca2+]i并导致血管舒张。我们最近开展了研究,以确定肾收缩细胞(包括入球小动脉、出球小动脉和系膜细胞)中钠钙交换体的存在及其调节机制。在所有这三种收缩成分中均存在交换体活性,但入球小动脉中的活性高于出球小动脉。我们还研究了钠钙交换体调节改变在自发性高血压大鼠(SHR)和盐敏感性高血压中的作用。在这两种高血压模型中,随着高血压的形成,入球小动脉而非出球小动脉中的钠钙交换体活性降低。在培养的系膜细胞和新鲜分离的入球小动脉中开展的其他研究表明,蛋白激酶C(PKC)可上调来自Dahl/Rapp盐抵抗大鼠的钠钙交换体,而在盐敏感大鼠的小动脉和系膜细胞中则不能。PKC对钠钙交换的这种调节缺陷是由于在S系膜细胞中PKC介导的交换体向质膜易位缺失所致。因此,PKC-钠钙交换体-易位途径的缺陷可能导致[Ca2+]i调节异常,并有助于解释在该高血压模型中出现的肾小球滤过率(GFR)显著下降。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验